Mark J. Litton

2.5k total citations · 1 hit paper
12 papers, 2.1k citations indexed

About

Mark J. Litton is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mark J. Litton has authored 12 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Mark J. Litton's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Mark J. Litton is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Mark J. Litton collaborates with scholars based in Sweden, United States and Belgium. Mark J. Litton's co-authors include Anne O’Garra, Maria Wysocka, Chyi‐Song Hsieh, Paulo Vieira, Giorgio Trinchieri, S E Macatonia, Kenneth M. Murphy, Nancy Hosken, Janice Culpepper and J S Abrams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Mark J. Litton

12 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.

1995 1.3k citations S E Macatonia, Nancy Hosken et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Litton Sweden	11	1.6k	290	280	259	181	12	2.1k
Kalle Söderström Sweden	27	3.2k 2.0×	518 1.8×	679 2.4×	502 1.9×	230 1.3×	39	3.9k
Foo Y. Liew United Kingdom	17	1.8k 1.1×	432 1.5×	202 0.7×	427 1.6×	259 1.4×	20	2.5k
Jonathan E. Boyson United States	27	2.6k 1.6×	383 1.3×	285 1.0×	311 1.2×	408 2.3×	55	3.2k
Fabio Almerigogna Italy	23	1.8k 1.1×	364 1.3×	311 1.1×	358 1.4×	120 0.7×	61	2.9k
Manthrasalam Rengaraju United States	8	1.3k 0.8×	165 0.6×	287 1.0×	289 1.1×	93 0.5×	10	1.7k
T. Petteri Arstila Finland	22	1.9k 1.2×	314 1.1×	359 1.3×	262 1.0×	131 0.7×	70	2.8k
Guillaume Oldenhove Belgium	17	1.7k 1.1×	382 1.3×	265 0.9×	266 1.0×	103 0.6×	28	2.3k
Sergio Arce United States	19	1.2k 0.8×	279 1.0×	247 0.9×	189 0.7×	54 0.3×	37	1.9k
Dominique Rigal France	23	779 0.5×	639 2.2×	395 1.4×	281 1.1×	143 0.8×	67	2.2k
Marisa Benagiano Italy	26	1.1k 0.7×	346 1.2×	298 1.1×	475 1.8×	73 0.4×	59	2.3k

Countries citing papers authored by Mark J. Litton

Since Specialization

Citations

This map shows the geographic impact of Mark J. Litton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Litton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Litton more than expected).

Fields of papers citing papers by Mark J. Litton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Litton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Litton. The network helps show where Mark J. Litton may publish in the future.

Co-authorship network of co-authors of Mark J. Litton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Litton. A scholar is included among the top collaborators of Mark J. Litton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Litton. Mark J. Litton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Litton, Mark J., Mikael Dohlsten, Alexander Rosendahl, et al.. (1999). The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens. British Journal of Cancer. 81(2). 359–366. 29 indexed citations

Litton, Mark J., Mikael Dohlsten, Johan Hansson, et al.. (1997). Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.. PubMed. 150(5). 1607–18. 30 indexed citations

MÜSSENER, Å., et al.. (1997). Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). Clinical & Experimental Immunology. 107(3). 485–493. 75 indexed citations

Roth, Irene, David B. Corry, Richard M. Locksley, et al.. (1996). Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10.. The Journal of Experimental Medicine. 184(2). 539–548. 285 indexed citations

Søgaard, Morten, Johan Hansson, Mark J. Litton, et al.. (1996). Antibody-targeted superantigens in cancer immunotherapy. Immunotechnology. 2(3). 151–162. 6 indexed citations

Litton, Mark J., Mikael Dohlsten, Peter A. Lando, et al.. (1996). Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma. European Journal of Immunology. 26(1). 1–9. 60 indexed citations

Ågren, Karin, Jan Andersson, Mark J. Litton, Keiko Funa, & Britt Nordlander. (1996). The Production of Immunoregulatory Cytokines is Localized to the Extrafollicular Area of Human Tonsils. Acta Oto-Laryngologica. 116(3). 477–485. 28 indexed citations

Dohlsten, Mikael, et al.. (1995). Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.. Proceedings of the National Academy of Sciences. 92(21). 9791–9795. 59 indexed citations

Macatonia, S E, Nancy Hosken, Mark J. Litton, et al.. (1995). Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.. The Journal of Immunology. 154(10). 5071–5079. 1281 indexed citations breakdown →

10.

Litton, Mark J., Birgitta Sander, Erin Murphy, Anne O’Garra, & John S. Abrams. (1994). Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B. Journal of Immunological Methods. 175(1). 47–58. 55 indexed citations

11.

Hunter, C.A., Mark J. Litton, Jack S. Remington, & J S Abrams. (1994). Immunocytochemical Detection Of Cytokines In The Lymph Nodes And Brains Of Mice Resistant Or Susceptible To Toxoplasmic Encephalitis. The Journal of Infectious Diseases. 170(4). 939–945. 37 indexed citations

12.

Andersson, Jan, et al.. (1994). Concomitant in vivo production of 19 different cytokines in human tonsils.. PubMed. 83(1). 16–24. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact